Neurohealth Properties ofHericium erinaceusMycelia Enriched with Erinacines
Open Access
- 21 May 2018
- journal article
- review article
- Published by Wiley in Behavioural Neurology
- Vol. 2018, 1-10
Abstract
Hericium erinaceus, an ideal culinary-medicinal mushroom, has become a well-established candidate in promoting positive brain and nerve health-related activities by inducing the nerve growth factor from its bioactive ingredient. Among its active compounds, only erinacine A has confirmed pharmacological actions in the central nervous system in rats. Hence, this review has summarized the available information on the neurohealth properties ofH. erinaceusmycelia enriched with erinacines, which may contribute to further research on the therapeutic roles of these mycelia. The safety of this mushroom has also been discussed. Although it has been difficult to extrapolate thein vivostudies to clinical situations, preclinical studies have shown that there can be improvements in ischemic stroke, Parkinson’s disease, Alzheimer’s disease, and depression ifH. erinaceusmycelia enriched with erinacines are included in daily meals.Keywords
This publication has 53 references indexed in Scilit:
- Transient pharmacologic lowering of Aβ production prior to deposition results in sustained reduction of amyloid plaque pathologyMolecular Neurodegeneration, 2012
- Erinacine A biosynthesis in submerged cultivation of Hericium erinaceum: Quantification and improved cultivationEngineering in Life Sciences, 2010
- Hericenones and erinacines: stimulators of nerve growth factor (NGF) biosynthesis inHericium erinaceusMycology, 2010
- Assessment of Depression in Three Medically ill, Elderly Populations: Alzheimer's Disease, Parkinson's Disease, and StrokeThe Clinical Neuropsychologist, 2009
- Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double‐blind placebo‐controlled clinical trialPhytotherapy Research, 2008
- Central Auditory Dysfunction in Older Persons With Memory Impairment or Alzheimer DementiaJAMA Otolaryngology–Head & Neck Surgery, 2008
- Long term treatment and disease severity change brain responses to levodopa in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Selfotel in Acute Ischemic StrokeStroke, 2000
- ERINACINE D, A STIMULATOR OF NGF-SYNTHESIS, FROM THE MYCELIA OF HERICIUM ERINACEUMHeterocyclic Communications, 1996
- Synthesis of (±)-Allocyathin B2 and (+)-Erinacine AJournal of the American Chemical Society, 1996